1. Sider L, Horejs D. Frequency of extrathoracic metastases from bronchogenic carcinoma in patients with normal-sized hilar and mediastinal lymph nodes on CT. AJR Am J Roentgenol. 1988; 151:893–895.
2. Song JU, Song J, Lee KJ, Kim H, Kwon OJ, Choi JY, et al. Are there any additional benefits to performing positron emission tomography/computed tomography scans and brain magnetic resonance imaging on patients with ground-glass nodules prior to surgery? Tuberc Respir Dis. 2017; 08. [Epub]. DOI:
10.4046/trd.2017.0050.
3. Changlai SP, Tsai SC, Chou MC, Ho YJ, Kao CH. Whole body 18F-2-deoxyglucose positron emission tomography to restage non-small cell lung cancer. Oncol Rep. 2001; 8:337–339.
4. van Tinteren H, Hoekstra OS, Smit EF, van den Bergh JH, Schreurs AJ, Stallaert RA, et al. Effectiveness of positron emission tomography in the preoperative assessment of patients with suspected non-small-cell lung cancer: the PLUS multicentre randomised trial. Lancet. 2002; 359:1388–1393.
5. Fischer B, Lassen U, Mortensen J, Larsen S, Loft A, Bertelsen A, et al. Preoperative staging of lung cancer with combined PET-CT. N Engl J Med. 2009; 361:32–39.
6. Maziak DE, Darling GE, Inculet RI, Gulenchyn KY, Driedger AA, Ung YC, et al. Positron emission tomography in staging early lung cancer: a randomized trial. Ann Intern Med. 2009; 151:221–228.
7. Yokoi K, Kamiya N, Matsuguma H, Machida S, Hirose T, Mori K, et al. Detection of brain metastasis in potentially operable non-small cell lung cancer: a comparison of CT and MRI. Chest. 1999; 115:714–719.
8. Penel N, Brichet A, Prevost B, Duhamel A, Assaker R, Dubois F, et al. Pronostic factors of synchronous brain metastases from lung cancer. Lung Cancer. 2001; 33:143–154.
9. Griffioen GH, Toguri D, Dahele M, Warner A, de Haan PF, Rodrigues GB, et al. Radical treatment of synchronous oligometastatic nonsmall cell lung carcinoma (NSCLC): patient outcomes and prognostic factors. Lung Cancer. 2013; 82:95–102.
10. Yohena T, Yoshino I, Kitajima M, Uehara T, Kanematsu T, Teruya T, et al. Necessity of preoperative screening for brain metastasis in non-small cell lung cancer patients without lymph node metastasis. Ann Thorac Cardiovasc Surg. 2004; 10:347–349.
11. Balekian AA, Fisher JM, Gould MK. Brain imaging for staging of patients with clinical stage IA non-small cell lung cancer in the national lung screening trial: adherence with recommendations from the choosing wisely campaign. Chest. 2016; 149:943–950.